ICON Plc (ICLR) Tuesday said fourth-quarter profit surged to $20.7 million or $0.34 per share from $4.1 million or $0.07 per share in the same period last year.
Adjusted earnings for the period was $60.4 million or $1.00 per share. On average 12 analysts polled by Thomson Reuters expected the company to earn $0.33 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues totaled $300 million, up 24 percent from $242.62 million last year. Analysts expected revenues of $291.96 million.
Looking ahead, the company has raised its full-year earnings guidance, reflecting acquisition of the clinical trial service division of Cross Country Healthcare, Inc.
The company currently projects full-year earnings in a range of $1.44 to $1.60 per share, up from previous guidance range of $1.40 to $1.55 per share. Revenues are forecast in a range of $1.26 billion to $1.29 billion, up from $1.21 billion to $1.24 billion announced previously.
Analysts, based on consensus, currently expect the company to report full-year earnings of $1.49 per share on revenues of $1.24 billion.
The company also said it has completed previously announced sale of its clinical trial services business for $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones.
Cross Country Healthcare used a portion of the net proceeds from this transaction to repay all $29.3 million of its outstanding bank debt.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.